Literature DB >> 29898215

The Urgent Need for Optimal Monitoring of Metabolic Adverse Effects in Children and Youngsters Who Take On-label or Off-label Antipsychotic Medication.

Marc De Hert1,2, Johan Detraux2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29898215     DOI： 10.1001/jamapsychiatry.2018.1080

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  4 in total

Review 1.  Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness.

Authors:  Victor Mazereel; Johan Detraux; Davy Vancampfort; Ruud van Winkel; Marc De Hert
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-09       Impact factor: 5.555

2.  Trends Over Time in Antipsychotic Initiation at a Large Children's Health Care System.

Authors:  Laura J Chavez; Kelly J Kelleher; Arne Beck; Gregory N Clarke; Robert B Penfold
Journal:  J Child Adolesc Psychopharmacol       Date:  2021-06       Impact factor: 3.031

3.  Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis.

Authors:  Celso Arango; Daisy Ng-Mak; Elaine Finn; Aidan Byrne; Antony Loebel
Journal:  Eur Child Adolesc Psychiatry       Date:  2019-11-22       Impact factor: 4.785

4.  Patterns and Predictors of Off-Label Drug Prescribing in Psychiatric Practice: A Qualitative Study.

Authors:  Sadia Shakeel; Shagufta Nesar; Hina Rehman; Khizra Jamil; Imran Ahsan Mallick; Muhammad Shahid Mustafa; Mudassir Anwar; Shazia Jamshed
Journal:  Pharmacy (Basel)       Date:  2021-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.